Overview Dividends

(SMG) Scotts Miracle-Gro - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8101861065

Fertilizer, Soil, Seed, Hydroponic, Pesticide

EPS (Earnings per Share)

EPS Growth (3y CAGR): -20.86%
EPS Trend (3y Corr): 1.3%

Last SUE: 0.04σ
Qual. Beats: 0

Revenue

Revenue Growth (3y CAGR): -10.56%
Revenue Trend (3y Corr): -7.5%

Last SUE: 0.09σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	44.1%
Value at Risk 5%th	60.6%
Relative Tail Risk	-16.53%

Reward TTM
Sharpe Ratio	-0.70
Alpha	-38.75

Character TTM
Hurst Exponent	0.313
Beta	0.992
Beta Downside	0.997

Drawdowns 3y
Max DD	48.26%
Mean DD	24.08%
Median DD	24.25%

Description: SMG Scotts Miracle-Gro November 07, 2025

The Scotts Miracle-Gro Company (NYSE: SMG) manufactures and sells a broad portfolio of lawn, garden, and indoor-hydroponic products across North America and select international markets, operating under well-known brands such as Scotts, Miracle-Gro, Ortho, and AeroGarden. Its core segments are Lawn & Garden (fertilizers, seed, pest control) and Hydroponics (lighting, nutrients, growing systems), which together serve mass-merchandisers, hardware chains, e-commerce platforms, and specialty growers.

In FY 2023 SMG reported revenue of approximately $4.5 billion, a 7% year-over-year increase driven largely by a 12% surge in Hydroponics sales, while adjusted EBITDA margin expanded to 14.2% versus 12.8% in FY 2022. The company’s earnings per share (diluted) were $2.20, and its free cash flow conversion remained above 80%, supporting a dividend yield near 1.5% and a modest share-repurchase program.

Key economic drivers include residential construction activity (which fuels lawn-care demand), weather volatility (affecting fertilizer usage), and the growing consumer shift toward indoor gardening and organic products-a trend reflected in SMG’s recent launch of Miracle-Gro Organic and expansion of the AeroGarden line. The sector’s base-rate growth is modest (≈2-3% CAGR for consumer lawn chemicals), but SMG’s diversified brand mix and premium-pricing power provide upside relative to peers.

For a deeper quantitative dive into SMG’s valuation and scenario analysis, the ValueRay platform offers a free model you might find useful.

SMG Stock Overview

Market Cap in USD	3,372m
Sub-Industry	Fertilizers & Agricultural Chemicals
IPO / Inception	1992-01-31
Return 12m vs S&P 500	-34.6%
Analyst Rating	4.36 of 5

SMG Dividends

Metric	Value
Dividend Yield	6.25%
Yield on Cost 5y	2.28%
Yield CAGR 5y	-21.01%
Payout Consistency	90.4%
Payout Ratio	71.0%

SMG Growth Ratios

Metric	Value
CAGR 3y	2.17%
CAGR/Max DD Calmar Ratio	0.04
CAGR/Mean DD Pain Ratio	0.09
Current Volume	731.2k
Average Volume	754.2k

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (145.3m TTM) > 0 and > 6% of Revenue (6% = 204.8m TTM)

FCFTA 0.09 (>2.0%) and ΔFCFTA -25.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.88% (prev 6.48%; Δ -0.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 315.7m > Net Income 145.3m (YES >=105%, WARN >=100%)

Net Debt (2.07b) to EBITDA (407.1m) ratio: 5.08 <= 3.0 (WARN <= 3.5)

Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (57.7m) change vs 12m ago 1.41% (target <= -2.0% for YES)

Gross Margin 30.59% (prev 23.94%; Δ 6.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 121.6% (prev 123.7%; Δ -2.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.99 (EBITDA TTM 407.1m / Interest Expense TTM 128.8m) >= 6 (WARN >= 3)

Altman Z'' 2.17

(A) 0.07 = (Total Current Assets 940.3m - Total Current Liabilities 739.7m) / Total Assets 2.74b

(B) 0.18 = Retained Earnings (Balance) 485.2m / Total Assets 2.74b

(D) -0.12 = Book Value of Equity -357.5m / Total Liabilities 3.10b

Total Rating: 2.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 57.04

1. Piotroski 3.50pt

2. FCF Yield 4.49%

3. FCF Margin 7.17%

4. Debt/Equity -5.89

5. Debt/Ebitda 5.08

6. ROIC - WACC (= 12.60)%

7. RoE -44.78%

8. Rev. Trend -7.54%

9. EPS Trend 1.27%

What is the price of SMG shares?

As of November 21, 2025, the stock is trading at USD 52.79 with a total of 731,200 shares traded.
Over the past week, the price has changed by -9.61%, over one month by -3.17%, over three months by -12.57% and over the past year by -26.86%.

Is SMG a buy, sell or hold?

Scotts Miracle-Gro has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy SMG.

Strong Buy: 7
Buy: 1
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SMG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	73.1	38.5%
Analysts Target Price	73.1	38.5%
ValueRay Target Price	53.5	1.3%

SMG Fundamental Data Overview November 15, 2025

Market Cap USD = 3.37b (3.37b USD * 1.0 USD.USD)
P/E Trailing = 23.6437
P/E Forward = 13.5135
P/S = 0.9879
P/B = 18.9789
P/EG = 0.2383
Beta = 1.968
Revenue TTM = 3.41b USD
EBIT TTM = 514.4m USD
EBITDA TTM = 407.1m USD
Long Term Debt = 2.14b USD (from longTermDebt, two quarters ago)
Short Term Debt = 57.2m USD (from shortTermDebt, last quarter)
Debt = 2.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 5.44b USD (3.37b + Debt 2.11b - CCE 36.6m)
Interest Coverage Ratio = 3.99 (Ebit TTM 514.4m / Interest Expense TTM 128.8m)
FCF Yield = 4.49% (FCF TTM 244.6m / Enterprise Value 5.44b)
FCF Margin = 7.17% (FCF TTM 244.6m / Revenue TTM 3.41b)
Net Margin = 4.26% (Net Income TTM 145.3m / Revenue TTM 3.41b)
Gross Margin = 30.59% ((Revenue TTM 3.41b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 6.07% (prev 31.82%)
Tobins Q-Ratio = 1.98 (Enterprise Value 5.44b / Total Assets 2.74b)
Interest Expense / Debt = 1.27% (Interest Expense 26.8m / Debt 2.11b)
Taxrate = 20.36% (-38.8m / -190.6m)
NOPAT = 409.7m (EBIT 514.4m * (1 - 20.36%))
Current Ratio = 1.27 (Total Current Assets 940.3m / Total Current Liabilities 739.7m)
Debt / Equity = -5.89 (negative equity) (Debt 2.11b / totalStockholderEquity, last quarter -357.5m)
Debt / EBITDA = 5.08 (Net Debt 2.07b / EBITDA 407.1m)
Debt / FCF = 8.46 (Net Debt 2.07b / FCF TTM 244.6m)
Total Stockholder Equity = -324.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.30% (Net Income 145.3m / Total Assets 2.74b)
RoE = -44.78% (negative equity) (Net Income TTM 145.3m / Total Stockholder Equity -324.5m)
RoCE = 28.39% (EBIT 514.4m / Capital Employed (Equity -324.5m + L.T.Debt 2.14b))
RoIC = 18.95% (NOPAT 409.7m / Invested Capital 2.16b)
WACC = 6.34% (E(3.37b)/V(5.48b) * Re(9.67%) + D(2.11b)/V(5.48b) * Rd(1.27%) * (1-Tc(0.20)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.88%
[DCF Debug] Terminal Value 63.47% ; FCFE base≈545.9m ; Y1≈358.4m ; Y5≈163.9m
Fair Price DCF = 43.53 (DCF Value 2.51b / Shares Outstanding 57.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 1.27 | EPS CAGR: -20.86% | SUE: 0.04 | # QB: 0
Revenue Correlation: -7.54 | Revenue CAGR: -10.56% | SUE: 0.09 | # QB: 0

Additional Sources for SMG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle